Choe Mangyu, Einav Tal, Phillips Rob, Titov Denis V
Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, California; Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, California.
Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California; Basic Sciences Division and Computational Biology Program, Fred Hutchinson Cancer Research Center, Seattle, Washington; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, California.
Biophys J. 2025 May 20;124(10):1562-1586. doi: 10.1016/j.bpj.2025.03.037. Epub 2025 Apr 3.
Glycolysis is a conserved metabolic pathway that produces ATP and biosynthetic precursors. It is not well understood how the control of mammalian glycolytic enzymes through allosteric feedback and mass action accomplishes various tasks of ATP homeostasis, such as controlling the rate of ATP production, maintaining high and stable ATP levels, ensuring that ATP hydrolysis generates a net excess of energy, and maintaining glycolytic intermediate concentrations within physiological levels. To investigate these questions, we developed a biophysical model of glycolysis based on enzyme rate equations derived from in vitro kinetic data. This is the first biophysical model of human glycolysis that successfully recapitulates the above tasks of ATP homeostasis and predicts absolute concentrations of glycolytic intermediates and isotope tracing kinetics that align with experimental measurements in human cells. We use the model to show that mass action alone is sufficient to control the ATP production rate and maintain the high energy of ATP hydrolysis. Meanwhile, allosteric regulation of hexokinase and phosphofructokinase by ATP, ADP, inorganic phosphate, and glucose-6-phosphate is required to maintain high ATP levels and to prevent uncontrolled accumulation of phosphorylated intermediates of glycolysis. Allosteric feedback achieves the latter by maintaining hexokinase and phosphofructokinase enzyme activity at one-half of ATP demand and, thus, inhibiting the reaction of Harden and Young, which otherwise converts glucose to supraphysiological levels of phosphorylated glycolytic intermediates at the expense of ATP. Our methodology provides a roadmap for a quantitative understanding of how metabolic homeostasis emerges from the activities of individual enzymes.
糖酵解是一种保守的代谢途径,可产生ATP和生物合成前体。目前尚不清楚通过变构反馈和质量作用对哺乳动物糖酵解酶的控制如何完成ATP稳态的各种任务,例如控制ATP产生的速率、维持高且稳定的ATP水平、确保ATP水解产生净过量的能量,以及将糖酵解中间产物浓度维持在生理水平内。为了研究这些问题,我们基于从体外动力学数据推导的酶速率方程开发了一个糖酵解的生物物理模型。这是第一个成功概括上述ATP稳态任务并预测与人类细胞实验测量结果一致的糖酵解中间产物绝对浓度和同位素示踪动力学的人类糖酵解生物物理模型。我们使用该模型表明,仅靠质量作用就足以控制ATP产生速率并维持ATP水解的高能量。同时,ATP、ADP、无机磷酸盐和6-磷酸葡萄糖对己糖激酶和磷酸果糖激酶的变构调节对于维持高ATP水平以及防止糖酵解磷酸化中间产物的不受控制积累是必需的。变构反馈通过将己糖激酶和磷酸果糖激酶的酶活性维持在ATP需求的一半来实现后者,从而抑制哈登和扬的反应,否则该反应会以ATP为代价将葡萄糖转化为超生理水平的磷酸化糖酵解中间产物。我们的方法为定量理解代谢稳态如何从单个酶的活性中产生提供了路线图。